ACR Convergence 2025

With the fall conference circuit in full swing, Nordic Bioscience’s rheumatology team is heading to the ACR Convergence 2025, taking place November 24–29 in Chicago, IL. As one of the largest gatherings in rheumatology, ACR offers a great opportunity to exchange ideas and showcase innovation in musculoskeletal research.

This year, we’re excited to be exhibiting and sharing the latest developments in our RheumaTrace™ platform—an advanced biomarker panel designed to provide deeper insights into disease activity, treatment response, and patient stratification in rheumatoid arthritis and other inflammatory joint diseases. RheumaTrace™ leverages tissue-specific biomarkers to quantify joint remodeling, supporting more targeted clinical decision-making and drug development.

If you’re attending ACR, make sure to visit our booth to explore how RheumaTrace™ and our broader biomarker portfolio can strengthen your research or clinical program. We look forward to meaningful discussions during this busy and impactful meeting season.